 The study population consists of all babies included in the INIS trial. The INIS trial was an RCT of intravenous immunoglobulin two infusions of 500 mgkg body weight polyvalent IgG versus placebo in the treatment of suspected or proven neonatal sepsis.5 3493 infants were included from 113 hospitals in nine countries.6 